The United States government is moving rapidly to secure Memorandums of Understanding (MOU) with African countries that offer limited health aid for five years in exchange for 25 years’ access to countries’ data about “pathogens with epidemic potential”. Some commentators have described the terms of the bilateral MOUs as “extractive” as they fail to offer […] Continue reading ->
This week, the world marks World Antimicrobial Awareness Week and malaria parasites, though often forgotten, are part of the range of microbes preventing us from achieving the Sustainable Development Goal of Good Health and Well-being. Malaria remains an immense public health burden, especially in Africa. It mainly affects the poor, and remains an immense health […] Continue reading ->
The 97% cure rate for the novel compound, ganaplacide/lumefantrine in a recent Phase 3 trial offers hope for continued progress rolling back malaria even as resistance to artemisinin combination therapies (ACT) escalates.  A next-generation antimalarial drug GanLum (ganaplacide/lumefantrine, KLU156) slightly outperformed a standard of care Artemisinin Combination Therapy (ACT) in a recent Phase 3 trial […] Continue reading ->
Canada has lost its measles elimination status after 12 months of continuous transmission of the highly infectious disease, the Pan-American Health Organization (PAHO) announced on Monday. This follows a PAHO expert meeting on infectious diseases last week, the Measles, Rubella, and Congenital Rubella Syndrome Elimination Regional Monitoring and Re-Verification Commission. “The commission determined that endemic […] Continue reading ->
Season 5 of the Global Health Matters podcast opens with a blunt diagnosis of the field’s future from two leading voices, and a roadmap for reform. In a conversation with host Garry Aslanyan, Paola Abril Campos Rivera of Tecnológico de Monterrey and Catherine Kyobutungi, head of Kenya’s African Population and Health Research Centre, argue that […] Continue reading ->